FIVE240719C120000
- 0.01
- -0.01-50.00%
Five Below Newsroom
Express News | Five Below Inc : Barclays Cuts Target Price to $90 From $176
Express News | Five Below Inc : Barclays Cuts to Equal-Weight From Overweight
Five Below, Inc. (FIVE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--$FIVE #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Five Below, Inc. ("Five Below" or "
Petco Names Joel Anderson as CEO Following Exit From Five Below -- Update
By Victor Swezey Petco Health and Wellness named Joel Anderson as its next chief executive, joining a remade executive team and board four months after former CEO Ron Coughlin stepped down from the
Five Below's Ex-CEO Is Going to Petco - but Could Find Similar Challenges
By Bill Peters Joel Anderson will become Petco's new CEO on July 29 Petco Health & Wellness Co. on Wednesday said that Joel Anderson - the former chief executive of teen-focused discount chain Five
Petco Appoints Five Below's Joel Anderson as CEO
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading
Consumer stocks were mixed in late Wednesday afternoon trading, with the Consumer Staples Select Sector SPDR Fund (XLP) adding 1.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY)
Five Below Faces Increased Competition From Temu, Shein -- Market Talk
Five Below's 2Q and full-year outlook cut might not only have come as a result of a challenging economic environment for lower income consumers, UBS analysts say in a research note. The discount
Five Below Is Maintained at Outperform by Telsey Advisory Group
Five Below Is Maintained at Outperform by Telsey Advisory
Five Below Might Need Steep Markdowns As It Plans Turnaround -- Market Talk
1423 ET - Five Below is now at crossroads as it deals with a lower-income customer base under pressure and deteriorating store productivity, according to Mizuho's David Bellinger. The analyst says
Express News | Guggenheim Maintains Buy on Five Below, Lowers Price Target to $125
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for
Why Five Below (FIVE) Shares Are Getting Obliterated Today
ASML, Five Below Fall; J&J, V.F. Corp. Rise; Wednesday, 7/17/2024
Five Below Price Target Cut to $124.00/Share From $163.00 by Goldman Sachs
Five Below Price Target Cut to $124.00/Share From $163.00 by Goldman
Analysts Offer Insights on Consumer Cyclical Companies: Chipotle (CMG), O-I Glass (OI) and Five Below (FIVE)
Five Below Faces Operational Challenges and Management Shifts, Maintains Neutral Rating
Wells Fargo Maintains Five Below(FIVE.US) With Buy Rating, Maintains Target Price $115
Wells Fargo analyst Edward Kelly maintains $Five Below(FIVE.US)$ with a buy rating, and maintains the target price at $115.According to TipRanks data, the analyst has a success rate of 61.9% and a
Five Below Down Over 21%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Five Below, Inc. (FIVE) is currently at $80.24, down $21.83 or 21.39% --Would be lowest close since April 23, 2020, when it closed at $78.42 --On pace for largest percent decrease since March 16, 2020
Five Below: Navigating Challenges With Proactive Strategies Merits a Buy Rating